Prescription

MRD / Regn No.

: 20260000570

Date

: 29/06/2026

Patient Name

: Vinoth Durai

Age & Gender

: 34 Yrs. / Male

Contact No.

: 9384331020

UHID

Ht / Wt / BMI

BP S / BP D

Allergies

: NKA

Referred By

Subjective	:	DM FOR 3 YEARS,CATARACT
Objective	:	THYROID PALPABLE
Analysis	:	DIABETES MELLITUS
Plan	:	START GLP1RA AND INSULIN,SEE ME IN 1 MONTHS,LIFESTYLE INSULIN AND GLP1RA USE SELF MONITORING AND TITRATION
Salient Investigations	:	ANTI GAD ANTIBODY: 2.1 IU/mL \| C PEPTIDE: 1.4 ng/mL

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	CAPSULE SEMAGLUTIDE SEMASIZE 0.25 Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION	SQ	ONCE A WEEK	AS DIRECTED NO RELATION TO FOOD	TILL NEXT VISIT
	MAY CAUSE NAUSEA VOMITING VISUAL DISTURBANCE

2	INJECTION DEGLUDEC / ASPART (INJ U100) 70/30 RYZODEG Medicine For DIABETES	SQ	0-12-0 UNITS	BEFORE FOOD	TILL NEXT VISIT
	MAY CAUSE HYPOGLYCEMIA

3	INJECTION GLUCOMETER ACCUCHEK GUIDE Medicine For DIAGNOSTIC PURPOSE ONLY	SQ

Refill : 0 / Substitution:

Education

: CHECK GLUCOSE EVERY 2 DAYS AND IF THE FASTING GLUCOSE IS CONSISTENTLY MORE THAN 90 INCREASE THE INSULIN BY 2 UNITS. THIS IS THE NEW DOSE. REPEAT THIS EVERY TWO DAYS UNTIL THE FASTING IS CONSISTENTLY LESS THAN 90

Next Visit

: 29/Jul/2026

Tests Suggested For Next Visit

: FBS 2HPP SMBG